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Tautomeric rearrangements on molecules lead to distinct
equilibrated structural states of the same chemical com-
pound, and evidently, have an impact on nearly all
aspects of computer-aided chemical data processing [1]
where the knowledge of the exact chemical structure is
required (e.g. the calculation of chemical properties or
interpretation of ligand-protein interactions). Although
tautomerism is a well-known and well-documented phe-
nomenon, it has long been disregarded in the field of drug
design, which, as a consequence, leads to a possible mis-
interpretation of ligand binding interactions. Especially
heuristic approaches, like structure-based pharmacophore
modeling, are techniques that allow for consideration of
several tautomeric forms, although this has not been done
systematically by now. Recent approaches in the area of
drug design mainly focus on virtual screening and tau-
tomer enrichment of existing compound databases [2].
However, the effect of tautomerism in deriving interaction
patterns within the protein-ligand complex (structure-
based 3D pharmacophore modeling) has not yet been
sufficiently addressed and thus leaves a wide and interest-
ing field for future investigations. In the presented work
various protein-ligand complexes have been studied
where the tautomeric states of the ligand have a significant
impact on derived 3D pharmacophores and the percep-
tion of binding modes, and also, tautomer-invariant phar-
macophore patterns are introduced. Furthermore, an
algorithm will be presented which enumerates all possible
tautomers on both the receptor and ligand side under the
constraints of a fixed active ligand conformation.
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